Love it or hate it, Jaguar seems determined to make us pay attention. All we’re given for now is a cropped view of the rear and the sides. The first thing you’ll likely notice is the complete ...

GSK’s (LSE: GSK) share price is down 28% from its 15 May 12-month traded high of £18.19. As a shareholder, this raises the question of whether I should sell, keep what I have, or buy more. In my ...

The GSK share price has tumbled recently on a number of factors, but I think its fundamentals look strong, leaving the stock undervalued right now. When investing, your capital is at risk.

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, positioning both companies to compete for that market and laying down a marker for ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...

This change allows the company more time to prepare a thorough and detailed submission for the National Institute for Health and Care Excellence (NICE). Price Action: GSK stock is down 0.56% at ...